1Bouloux PM,Hu Y,MacColl G.Recent advances in the pathogenesis of Kallmann's syndrome[J].Prog Brain Res,2002,141:79-83.
2Albuisson J,Pecheux C,Carel JC,et al.Kallmann syndrome:14 novel mutations in KAL1 and FGFR1 (KAL2)[J].Hum Mutat,2005,25 (1):98-99.
3Soderlund D,Vilchis F,Mendez JP.Polymorphic changes in the KAL1 gene:not all of them should be classified as polymorphisms[J].J Endocrinol Invest,2004,27 (8):765-769.
4Massin N,Pecheux C,Eloit C,et al.X chromosome-linked Kallmann syndrome:clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene[J].J Clin Endocrinol Metab,2003,88 (5):2003-2008.
9Sato N,Katsumata N,Kagami M,et al.Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1,or KAL2) in five families and 18 sporadic patients[J].J Clin Endocrinol Metab,2004,89 (3):1079-1088.
10Soderlund D,Canto P,Mendez JP.Identification of three novel mutations in the KAL1 gene in patients with Kallmann syndrome[J].J Clin Endocrinol Metab,2002,87 (6):2589-2592.
